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A B S T R A C T
Objective: To determine if bicarbonate values from venous blood gas (VBG) and
plasma chemistry samples provided agreement in determining the bicarbonate criteria for the diagnosis and/or resolution of diabetic ketoacidosis (DKA).
Methods: A retrospective chart review of data from patients admitted to a tertiary care hospital with a diagnosis of DKA over a four year period was performed. Paired
bicarbonate values from a VBG and chemistry panel, if drawn within 60minutes of each other, were compared.
Results: At the time of diagnosis of DKA, 197 paired bicarbonate values were available for analysis with the mean difference between the two methods of testing of
2.5 mmol/L. 16 of the 197 (8%) paired values were discordant in meeting criteria for diagnosis of DKA. At the time of resolution of DKA, 83 paired bicarbonate
samples were compared. The mean difference was 2.3 mmol/L. 20 of the 83 (24%) paired bicarbonate values showed discordance with regards to meeting the
bicarbonate criteria for resolution of DKA.
Conclusion: Discordance between bicarbonate results from different analysis methods may lead to different determinations as to whether or not a patient meets the
biochemical definition for diagnosis and resolution of DKA.
Diabetic ketoacidosis (DKA) is a severe acute complication of un-
controlled diabetes. This diabetic emergency is diagnosed by the fol-
lowing criteria: blood glucose > 250mg/dl, the presence of ketonemia
and the presence of acidosis (arterial pH≤ 7.30 and bicarbo-
nate≤ 18mmol/L) [1]. Treatment includes correcting fluid and elec-
trolyte abnormalities and administering insulin to correct the acidosis
and lower blood glucose levels. The use of an insulin infusion, espe-
cially in the setting of severe DKA, is considered the standard of care.
Patients with DKA are monitored more frequently with clinical and
laboratory evaluation than patients with hyperglycemia and no other
metabolic abnormalities. In order to determine when DKA has resolved,
once blood sugars are less than 200mg/dl, two of the following three
criteria should be met: pH > 7.30, normalization of the anion gap and
increase of the bicarbonate level to≥ 15mmol/L [1].
Traditionally, a chemistry panel has been used to determine elec-
trolyte levels including bicarbonate levels. In practice however, clin-
icians may use bicarbonate levels obtained from a venous chemistry
panel or via arterial or venous blood gas analysis. The advantages of
using a venous blood gas (VBG) include the avoidance of potential
trauma and pain associated with an arterial blood gas draw, which can
be technically difficult, and a more rapid processing time compared to a
venous chemistry sample. However, venous chemistry samples provide
other relevant information such as creatinine, and the benefit of a
measured serum bicarbonate level whereas bicarbonate results from a
VBG are calculated via the Henderson-Hasselbalch equation based on
direct measurement of pH and PCO2. The causes and extent of the
discordance between measured and calculated bicarbonate values has
been discussed in other work. Some studies have found differences
between measured and calculated bicarbonate to be clinically insig-
nificant [2–4], though others have not [5,6].
There have been several studies comparing bicarbonate values from
arterial blood gas (ABG) to VBG samples in DKA, but not many com-
paring the use of values from a VBG vs a chemistry panel [7–11]. There
have been no studies evaluating the implications of using VBG bi-
carbonate levels to evaluate DKA resolution. The purpose of our study
was to compare the results of VBG and plasma chemistry bicarbonate
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levels obtained in the setting of routine medical care at the time of both
the diagnosis and resolution of DKA to determine whether the results
would show concordance as to the biochemical status of the patient.
Methods
Study Design: The study, which was approved by the Boston
University Medical Center Institutional Review Board, is a retrospective
chart review of data from patients admitted to the institution over a
four year period between 2011 and 2014. The initial data was extracted
from the electronic medical record (EMR) using ICD-9 diagnostic codes
for DKA (250.12 and 250.13) and investigators subsequently reviewed
each chart to confirm eligibility. Patients were included in the study if
they were 18 years of age or older at the time of admission, were ad-
mitted to the hospital with a diagnosis of DKA and had a bicarbonate
value from a VBG and chemistry panel within 60min of each other at
the time of diagnosis and/or at the time of resolution of DKA. For the
diagnosis of DKA, the criteria of blood glucose > 250mg/dl, presence
of ketones in urine or blood, serum pH≤ 7.30 and bicarbo-
nate≤ 18mmol/L (on a VBG or chemistry panel) was used. In cases
where urine and blood ketones were not checked, if the history and
presentation was consistent with a probable diagnosis of DKA, the data
was included for analysis. To determine resolution by bicarbonate cri-
teria, the first bicarbonate value≥ 15mmol/L, either on a VBG or
chemistry panel, was selected. If the chemistry panel was the first to
show diagnosis of DKA or resolution by bicarbonate criteria, a paired
value from the VBG panel within 60min was documented and vice
versa. If no paired bicarbonate value was available, the data was not
included for analysis. The bicarbonate level on the chemistry panel was
determined by using Architect c8000 (Abbott Diagnostics, Abbott Park,
IL) via a PEP carboxylase reaction and venous blood gas analysis was
performed using Radiometer ABL800 FLEX analyzer (Radiometer, Brea,
CA). Bicarbonate values from VBG samples are calculated using the
Henderson-Hasselbalch (HH) equation: pH=pKa+ log10 ([HCO3–]/
[H2CO3]). All of the measurements were performed in the chemistry
laboratory at the Boston Medical Center as part of the patients’ routine
clinical care.
Data Analysis: General characteristics were analyzed using standard
descriptive statistics. Paired bicarbonate values from VBG and chem-
istry panels at the time of diagnosis or resolution of DKA were com-
pared if drawn within 60min and 30min of each other. Student’s t test
was used for comparison. If the bicarbonate value was resulted as <
5mmol/L on the chemistry panel or VBG, a value of 5mmol/L was
used for analysis.
Results
Data from 313 admissions were obtained from the EMR based on
age and diagnostic code criteria. After reviewing each admission, 95
were excluded for not meeting criteria for DKA, 13 did not have paired
bicarbonate values at the time of diagnosis and/or resolution of DKA
and three were not unique inpatient admissions. 202 admissions were
included for the final analysis. Table 1 outlines the basic demographic
characteristics and admission laboratory values for the study cohort.
At the time of diagnosis of DKA, 197 paired bicarbonate values were
available for analysis that were drawn within 60min of each other, 191
samples that were drawn within 30min of each other and 165 of these
were drawn simultaneously. The mean bicarbonate level from the VBG
and chemistry panels were 11.38 ± 4.51 and 9.01 ± 3.48 respec-
tively. The mean difference between the paired samples was
2.5 ± 1.7mmol/L (range 0–9.4mmol/L) and was statistically sig-
nificant (p < 0.01). With regards to the clinical significance of these
differences, 16 of the 197 paired values were discordant in meeting the
bicarbonate level criteria for the diagnosis of DKA. In all 16 cases, the
bicarbonate value from the VBG sample was > 18mmol/L and would
exclude a diagnosis of DKA.
While being treated for DKA, 83 admissions had paired bicarbonate
samples (with at least one value≥ 15mmol/L) within 60min of each
other and 75 within 30min of each other. 49 of the paired samples were
drawn simultaneously. The mean bicarbonate level from the VBG and
chemistry panels were 18.2 ± 2.37mmol/L and 16.11 ± 2.27mmol/
L respectively. Similar to the labs drawn at the time of diagnosis of
DKA, there was a statistically significant difference between bicarbo-
nate values from the VBG and the chemistry panel (p < 0.01). The
mean difference was 2.3 ± 1.3mmol/L (range 0–5.8mmol/L). 20 of
the 83 paired bicarbonate values showed discordance with regards to
meeting the bicarbonate level criteria for resolution of DKA. Eighteen of
these samples did not meet the criteria based on the bicarbonate value
from the chemistry panel and the remaining two did not meet criteria
based on the VBG bicarbonate level.
Discussion
In the acute setting, identification of DKA and its severity helps in
the triage of patients to an appropriate level of care. Furthermore,
providers may choose to manage patients differently if the patient
meets a biochemical diagnosis of DKA, such as using higher insulin
doses or an insulin infusion, or to determine if the patient is felt to be
stable to discharge back to the community. An admission for the di-
agnosis of DKA may influence the treatment that is recommended for
the patient upon discharge from the hospital. Similarly, providers await
the improvement of bicarbonate as a marker that the patient is stable
for transition off an insulin infusion. While the absolute difference be-
tween some of the paired bicarbonate levels was not great, the use of
threshold cutoff values to determine resolution means that even a
slightly lower value may cause the provider to delay transition to
subcutaneous insulin therapy, or potentially transition prematurely.
While prior recommendations for a bicarbonate cutoff to determine the
resolution of DKA was ≥18mEq/L, more recently the recommended
cut-off is≥ 15mEq/L [1,12]. It is not known if one cut-off is clinically
superior in terms of patient outcomes, or if small differences in bi-
carbonate levels at the time of transition to subcutaneous insulin have
an impact on outcomes.
As mentioned previously, several studies have looked at the corre-
lation between measured and calculated bicarbonate levels and de-
termined in most situations the absolute differences are not large and
therefore not clinically significant. In one study, Kobold et al. compared
measured venous bicarbonate and calculated arterial bicarbonate re-
sults drawn concurrently on 17,621 samples. This group found the
mean difference to be 0.36mmol/L, and agreement of values within
3mmol/L in 98.5% of samples [13]. Another study of 1820 simulta-
neously drawn ABG and venous chemistry samples showed overall good
correlation, however significant discrepancies between certain calcu-
lated and measured values, in particular when bicarbonate values were
lower [14]. There is limited data comparing different bicarbonate
Table 1
Demographics and baseline laboratory profile of the study cohort at the time of
admission and diagnosis of DKA.
Demographic Data
Age (years) [mean ± SD (range)] 41.49 ± 15.74 (18–88)
Gender
- Male [%] 121 (59.9%)
- Female [%] 81 (40.1%)
Baseline Laboratory Data
Glucose (mg/dL) [mean ± SD (range)] 633.83 ± 272.33 (251–1971)
Bicarbonate level (mmol/L), [mean ± SD
(range)]
8.96 ± 3.41 (5–18)
pH [mean ± SD] 7.17 ± 0.1
Anion gap [mean ± SD] 25.74 ± 5.67
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measurement methods in patients with DKA. In a prospective ob-
servational analysis of data from patients admitted to the emergency
department, Menchine et al. compared the accuracy of VBG electrolytes
including bicarbonate levels for diagnosing DKA to plasma chemistry
panels for diagnosing DKA [15]. Of 342 patients with paired VBG and
serum chemistry panels, 46 were diagnosed with DKA. This study found
that the sensitivity and specificity of VBG electrolytes in the diagnosis
of DKA were 97.8% and 100% respectively.
There are a number of factors that are known to contribute to dif-
ferences between measured and calculated bicarbonate values. These
include assay interference, loss of CO2 gas during processing, CO2 ac-
cumulation due to tourniquet induced venous stasis, and variation of pḰ
from the assumed value in the HH equation, among others [5,16–18].
One case report determined the wide difference between measured and
calculated results in an individual patient to be due to human error
when calculating the HCO3– from the VBG [19]. While clinicians may in
general feel more comfortable relying on the results of a measured
value, other studies have demonstrated potential interference from li-
pemia and paraproteinemia with chemistry panel bicarbonate results,
including those that use photospectometric analysis [16,20].
In our study, we found a clear bias toward measured chemistry
values being lower than values calculated for VBG results (Fig. 1). The
reasons for this difference were not clear. We considered whether time
between sample draws might have allowed time for an actual change to
have occurred in the patients’ bicarbonate value. However, we did not
find a correlation when comparing time difference between samples
(Fig. 2a, b), or that later values were consistently higher than values
obtained earlier in the patients’ clinical course. We also considered if
sample processing delay could have affected measured bicarbonate
results as chemistry samples take longer to transport and process.
However, our lab undertook a quality review and measured bicarbonate
on serial samples over several hours, and it did not find any significant
change in measured values when sample measurement was delayed
with time.
Our current study has several strengths. First, all patients were de-
termined to meet criteria for DKA by investigator chart review, and we
did not rely on ICD-9 code alone. Furthermore, the same instruments
were used during the course of the study to analyze samples. Finally,
these samples were all obtained in the course of routine clinical care,
and would reflect values that were available to assist providers in the
care of patients in real-time. However, there are also some limitations
to this work. As this was a retrospective analysis of data, it has the
limitation of not controlling for pre-analytic factors that could affect the
bicarbonate results. Since beta hydroxybutyrate and urine ketone levels
were not available for all patients (24 of 202 patients), there could have
been an incorrect diagnosis of DKA and inclusion in the study cohort.
Not all paired bicarbonate levels were drawn at the same time, and we
cannot completely rule out any effects of a time delay, though as
mentioned above we did not see any correlation. A prospective study
where paired samples are drawn and analyzed simultaneously could
potentially decrease some sources of variation. Additionally, our find-
ings are based on the performance of the particular blood gas and
chemistry analyzers used at our institution. Clinical application of this
study would need to take into account these factors when applying it to
other populations and institutions. Finally, our study does not help us
determine the “right” method (measured vs calculated bicarbonate) to
use in all clinical situations. It also is not an assessment on whether VBG
can replace ABG testing which plays an important role in the diagnosis
of DKA. While the tendency of the provider may be to rely on measured
values, the limitations of these assays must be understood, and in
particular in patients in whom there is a wide discordance between
measured and calculated values further investigation should be
Fig. 1. Comparison of bicarbonate results by different methods.
Fig. 2. Differences in bicarbonate values from VBG and chemistry panel for
individual patients at (A) the time of diagnosis of DKA and (B) time of re-
solution of DKA.
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undertaken.
In conclusion, our study demonstrates discordance in some patients
when establishing the criteria for a diagnosis or determining resolution
of DKA depending on the method used to assess bicarbonate. Clinicians
should consider the limits of laboratory testing when making diagnostic
and treatment decisions.
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